Omega-3 fatty acids in the prevention of atrial fibrillation recurrences after cardioversion: A meta-analysis of randomized controlled trials

Internal Medicine

Volumn 51, Issue 18, 2012, Pages 2503-2508

  Cao, Hong ^a   Wang, Xin ^a   Huang, He ^a   Ying, Shao Zhen ^a   Gu, Yong Wei ^a   Wang, Teng ^a   Huang, Cong Xin ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Cardioversion; Meta analysis; Omega 3 fatty acids

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; FISH OIL; OMEGA 3 FATTY ACID; PLACEBO; SOTALOL; STATIN;

ARTICLE; BODY MASS; CARDIOVERSION; DRUG EFFICACY; DRUG WITHDRAWAL; ELECTROCARDIOGRAPH; FOLLOW UP; GASTROINTESTINAL DISEASE; HEART ATRIUM FIBRILLATION; HUMAN; MANTEL HAENSZEL TEST; META ANALYSIS; MULTICENTER STUDY (TOPIC); OBESITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

AGED; ATRIAL FIBRILLATION; ELECTRIC COUNTERSHOCK; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84867857523     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.7714     Document Type: Article

References (29)

1. Lafuente-Lafuente C, Mouly S, Longas-Tejero MA, Bergmann JF. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst Rev 17: CD005049,2007
2. Mozaffarian D, Psaty BM, Rimm EB, et al. Fish intake and risk of incident atrial fibrillation. Circulation 110: 368-373, 2004
3. Virtanen JK, Mursu J, Voutilainen S, Tuomainen TP. Serum longchain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men. Circulation 120: 2315-2321, 2009
4. Nodari S, Triggiani M, Campia U, et al. n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study. Circulation 124: 1100-1106, 2011
5. Kumar S, Sutherland F, Morton JB, et al. Long-term omega-3 polyunsaturated fatty acid supplementation reduces the recurrence of persistent atrial fibrillation after electrical cardioversion. Heart Rhythm 9: 483-491, 2012
6. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized linical trials: is blinding necessary? Control Clin Trials 17: 1-12, 1996
7. Margos P, Leftheriotis D, Katsouras G, et al. Influence of n-3 fatty acids intake on secondary prevention after cardioversion of persistent atrial fibrillation to sinus rhythm. Europace 9: 51, 2007
8. Erdogan A, Bayer M, Kollath D. Omega af study: polyunsaturated fatty acids (PUFA) for prevention of atrial fibrillation relapse after successful external cardioversion. Heart Rhythm 4: S185, 2007
9. Bianconi L, Calò L, Mennuni M. n-3 Polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized,double-blind, multicentre study. Europace 13: 174-181, 2011
10. Ozaydin M, Erdoǧan D, Tayyar S, et al. N-3 polyunsaturated fatty acids administration does not reduce the recurrence rates of atrial fibrillation and inflammation after electrical cardioversion: a prospective randomized study. Anadolu Kardiyol Derg 11: 305-309,2011
11. Cunha DN, Hamlin RL, Billman GE, Carnes CA. n-3 (omega-3) polyunsaturated fatty acids prevent acute atrial electrophysiological remodeling. Br J Pharmacol 150: 281-285, 2007
12. Laurent G, Moe G, Hu X, et al. Long chain n-3 polyunsaturated fatty acids reduce atrial vulnerability in a novel canine pacing model. Cardiovasc Res 77: 89-97, 2008
13. Ninio DM, Murphy KJ, Howe PR, Saint DA. Dietary fish oil protects against stretch-induced vulnerability to atrial fibrillation in a rabbit model. J Cardiovasc Electrophysiol 16: 1189-1194, 2005
14. Jahangiri A, Leifert WR, Patten GS, McMurchie EJ. Termination of asynchronous contractile activity in rat atrial myocytes by n-3 polyunsaturated fatty acids. Mol Cell Biochem 206: 33-41, 2000
15. Sarrazin JF, Comeau G, Daleau P, et al. Reduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogs. J Am Coll Cardiol 50:1505-1512, 2007
16. Heidarsdottir R, Arnar DO, Skuladottir GV, et al. Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery? Europace 12: 356-363, 2007
17. Nichol G, McAlister F, Pham B, et al. Meta-analysis of randomized controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation. Heart 87: 535-543, 2002
18. Dobrev D, Nattel S. New antiarrhythmic drugs for treatment of atrial fibrillation. Lancet 375: 1212-1223, 2010
19. Li GR, Sun HY, Zhang XH, et al. Omega-3 polyunsaturated fatty acids inhibit transient outward and ultra-rapid delayed rectifier K+ currents and Na+ current in human atrial myocytes. Cardiovasc Res 81: 286-293, 2009
20. Honen BN, Saint DA. Polyunsaturated dietary fats change the properties of calcium sparks in adult rat atrial myocytes. J Nutr Biochem 13: 322-329, 2002
21. Mayyas F, Sakurai S, Ram R, et al. Dietary omega3 fatty acids modulate the substrate for post-operative atrial fibrillation in a canine cardiac surgery model. Cardiovasc Res 89: 852-861, 2011
22. Zhang Z, Zhang C, Wang H, et al. n-3 polyunsaturated fatty acids prevent atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Int J Cardiol 153: 14-20, 2011
23. Patel P, Dokainish H, Tsai P, Lakkis N. Update on the association of inflammation and atrial fibrillation. J Cardiovasc Electrophysiol 21: 1064-1070, 2010
24. Mori TA, Beilin LJ. Omega-3 fatty acids and inflammation. Curr Atheroscler Rep 6: 461-467, 2004
25. Metcalf RG, James MJ, Gibson RA, et al. Effects of fish-oil supplementation on myocardial fatty acids in humans. Am J Clin Nutr 85: 1222-1228, 2007
26. Saravanan P, Bridgewater B, West AL, ONeill SC, Calder PC,Davidson NC. Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery:a randomized, double-blind, placebo-controlled clinical trial. CircArrhythm Electrophysiol 3: 46-53, 2010
27. Leon H, Shibata MC, Sivakumaran S, Dorgan M, Chatterley T,Tsuyuki RT. Effect of fish oil on arrhythmias and mortality: systematic review. BMJ 337: a2931, 2008
28. Sakabe M, Shiroshita-Takeshita A, Maguy A, et al. Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling. Circulation 116: 2101-2109, 2007
29. Ramadeen A, Laurent G, dos Santos CC, et al. n-3 polyunsaturated fatty acids alter expression of fibrotic and hypertrophic genes in a dog model of atrial cardiomyopathy. Heart Rhythm 7: 520-528, 2010